CNN: One of the leading coronavirus vaccine trials is currently paused. Prominent vaccine researchers say that's unusual

UC expert says phase III trials typically don't pause

Recently, one of the major trials being conducted for a COVID-19 vaccine was paused because a study volunteer had what's known as an "adverse event." Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine was interviewed by CNN for a story on the pause in the AstraZeneca COVID-19 vaccine trial. 

Professor Carl J. Fichtenbaum, MD shown here his in lab at MSB. UC/ Joseph Fuqua UC/Joseph Fuqua II

Carl Fichtenbaum, MD, of the UC College of Medicine Division of Infectious Diseases. Photo/Joseph Fuqua III/UC Creative + Brand

Fichtenbaum said it was uncommon for a pause to happen in a phase III trial.

According to Fichtenbaum, "Phase 3 trials don't typically pause. I've only seen it handful of times in my experience."

Read the entire story here.

Fichtenbaum was also featured in a story on vaccine trial volunteers aired by several Hearst television stations, including WCVB in Boston

Impact Lives Here

The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.

Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.

Related Stories

1

The next generation of care

April 15, 2024

University of Cincinnati student-led nonprofit organization Parkinson's Together takes a multidisciplinary approach to meeting the needs of patients with Parkinson's disease in their community. Now it's setting a model for student organizations across the country.

Debug Query for this